Home
About
Overview
Sharing Data
ORCID
Help
History (15)
Pulmonary Emphysema
Institutional Management Teams
Colonic Diseases
Subcutaneous Infliximab (CT-P13 SC) as Maintenance Therapy for Inflammatory Bowel Disease: Two Randomized Phase 3 Trials (LIBERTY).
Survival rates after resection for localized kidney cancer: 1989 to 2004.
See All 15 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Survival rates after resection for localized kidney cancer: 1989 to 2004.
Survival rates after resection for localized kidney cancer: 1989 to 2004. Cancer. 2008 Jul 01; 113(1):84-96.
View in:
PubMed
subject areas
Carcinoma, Renal Cell
Disease-Free Survival
Female
Humans
Kidney Neoplasms
Male
Nephrectomy
Survival Rate
Time Factors
authors with profiles
Scott Eggener